Current Funding

Global Lyme Alliance (PI: Nigrovic)

A Pediatric Multi-center Lyme Disease Research Network with Biosample Collection

National Institute of Allergy and Infectious Diseases (PI: Nigrovic)

Comparative Effectiveness of Intravenous Ceftriaxone Compared with Oral Doxycycline in Lyme Meningitis

Department of Defense (PIs: Nigrovic/Steen)

Host-based Proteomic Biosignatures for the Diagnosis of Lyme disease in Children

Peabody Foundation (PI: Nigrovic/Nigrovic)

New Tools to Diagnose Lyme Disease in Children

Emergency Medicine Foundation (PI: Nigrovic)

Multiplex PCR Assay for the Diagnosis of Tick-borne Infections in Children

Fairbairn Family Lyme Research Initiative (PI: Nigrovic/Kong)

Novel Gene Expression Signatures for Children with Acute Neurologic Lyme Disease

National Institute of Allergy and Infectious Diseases (PI: Belisle)

Host Metabolic Biosignatures for the Diagnosis of Lyme

Past Funding

Department of Defense (PI: Belisle)

Metabolic Biosignature of Lyme Disease in Human Urine

Joint Biology Consortium Microgrant (PI: Nigrovic)

Novel Microarray Biosignature for Lyme Arthritis in Children

Department of Defense (PI: Chiu)

Development and Validation of a Combined Pathogen Host Assay for Lyme Disease and Other Tick Borne Infections

Milton Foundation, Harvard University (PI: Nigrovic)

Novel Multiplex Assay for the Diagnosis of Lyme Disease Facial Palsy in Children

NIAID R34 (PI: Garro)

Trial of Oral Antibiotics for the Treatment of Childhood Lyme Meningitis

Boston Children’s Hospital Medical Staff Office (PI: Nigrovic)

C6 EIA for Children with Inflammatory Arthritis Presenting to the Emergency Department

Bay Area Lyme Disease Foundation (PI: Nigrovic)

Novel Approach for the Diagnosis of Lyme Disease in Children

Centers for Disease Control and Prevention, Division of Vector Control (PI: Nigrovic)

Evaluation of a Lyme Disease Metabolomic Biosignature in Children

Boston Children’s Hospital Research Faculty Council (PI: Nigrovic)

Novel Diagnostics for Lyme Disease

Harvard Catalyst Early Clinical Data (PI: Nigrovic)

Serologic Diagnostics for Lyme Disease